Evidence map›Paper›PMID 40837604›Full record

ArticlePhysics and imaging in radiation oncology2025

Hybrid deep learning enables multi-institutional delineation of active bone marrow for gynecologic radiotherapy.

Zhe Zhang, Xiao Lu, Sicheng He, Tao Huang, Shaobin Wang, Mingjun Lu, Xiaomin Zhang, Zhibo Tan, John Moraros, Lei Zhang and 7 more

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Zhe ZhangDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
Xiao LuDepartment of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Sicheng HeInterventional Diagnostic Centre, Zhongnan Hospital Wuhan University, Wuhan, China.
Tao HuangDepartment of Biosciences and Bioinformatics, Suzhou Municipal Key Lab AI4Health, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
Shaobin WangDepartment of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China.
Mingjun LuDepartment of Radiology, Zhujiang Hospital Southern Medical University, Guangzhou, China.
Xiaomin ZhangDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
Zhibo TanDepartment of Radiation Oncology, Proton and Heavy Ion Center, Heyou Hospital, Heyou International Health System, Foshan, Guangdong, China.
John MorarosDepartment of Biosciences and Bioinformatics, Suzhou Municipal Key Lab AI4Health, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
Lei ZhangDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
Xin LiDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
Zhan LiDepartment of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Zihao DengCollege of Life Sciences and Oceanography, Shenzhen University, Shenzhen, China.
Yimeng ZhangDepartment of Research and Development, MedMind Technology Co, Ltd., Beijing, China.
Mengjie DongDepartment of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Shuihua WangDepartment of Biosciences and Bioinformatics, Suzhou Municipal Key Lab AI4Health, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
Yajie LiuDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Hong Kong University of Science and Technology Medical Center, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Pelvic radiotherapy for gynecologic cancer inevitably irradiates sensitive areas like iliac bones, lumbar vertebrae, and sacrum. Using Materials and methods: We analyzed 319 patients from five institutions retrospectively. ABM was divided into three 18F-FDG PET/CT-defined subregions: active iliac bone marrow (A_IBM), active sacral bone marrow (A_SBM), and active lumbar vertebrae bone marrow (A_LVBM), defined as areas with standardized uptake values exceeding subregional means. Six deep learning models were trained: hybrid nnU-Net, U-Net, V-Net, ResU-Net, nnU-Net, and UNETR. The hybrid nnU-Net approach integrated nnU-Net predictions with anatomical bone structures via Boolean operations, providing a post-processing strategy. The dataset was split into 290 cases for training and 29 for independent testing. Performance was evaluated using Dice similarity coefficients (DSCs) and 95th percentile Hausdorff distance (HD95). Two clinical cases were prospectively evaluated for ABM-sparing radiotherapy with hematologic monitoring. Results: The hybrid nnU-Net achieved the highest DSCs for A_IBM (0.74 ± 0.06), A_LVBM (0.79 ± 0.07), and A_SBM (0.75 ± 0.06), with significant improvements over most models (p < 0.001), except nnU-Net. Despite ResU-Net's lower HD95 in two subregions, hybrid nnU-Net showed superior accuracy. No grade ≥2 hematologic toxicity occurred in prospective cases. Conclusion: This multi-institutional study confirms that the hybrid nnU-Net accurately segments ABM from CT images, showing potential for ABM-sparing radiotherapy.

Indexed as

Active bone marrowGynecologic radiotherapyHematologic toxicityHybrid deep learning segmentationMulti-institutional study

Identifiers

PMID40837604
PMCPMC12361777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.